Research in catalysis has the potential to lead to novel diabetes treatments. By studying the catalytic pathways involved in insulin signaling and glucose metabolism, researchers can identify new drug targets. Additionally, biocatalysts are being explored to develop more efficient methods for producing insulin and other therapeutics, potentially reducing costs and improving accessibility.
